Trial intelligence / Profile preview

Alendronate vs Calcium in Postmenopausal Osteoporosis

NCT00398606Phase 3Completed

Sponsor
Organon & Co.
Start
Apr 1995
Primary completion
Feb 1998
Modality
Small Molecules
01

Overview

A Phase 3 trial of alendronate in postmenopausal osteoporosis, sponsored by Organon & Co.. Started Apr 1995; status: completed.

02

Drugs

alendronate
03

Conditions

postmenopausal osteoporosis

Beyond the preview

Go deeper on NCT00398606.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00398606.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call